As of 2025-03-21, the Relative Valuation of Cannara Biotech Inc (LOVE.CN) is (0.39) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 CAD, the upside of Cannara Biotech Inc based on Relative Valuation is -426.5%.
The range of the Relative Valuation is (0.38) - (0.41) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.2x - 23.2x | 22.2x |
| Forward P/E multiples | 19.5x - 22.1x | 20.8x |
| Fair Price | (0.38) - (0.41) | (0.39) |
| Upside | -417.5% - -440.4% | -426.5% |
| Date | P/E |